Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial.

Autor: Kibengo, Freddie M.1, Ruzagira, Eugene1, Katende, David1, Bwanika, Agnes N.1, Bahemuka, Ubaldo1, Haberer, Jessica E.2, Bangsberg, David R.2, Barin, Burc3, Rooney, James F.4, Mark, David5, Chetty, Paramesh6, Fast, Patricia7, Kamali, Anatoli1, Priddy, Frances H.7 fpriddy@iavi.org
Zdroj: PLoS ONE. Sep2013, Vol. 8 Issue 9, p1-1. 1p.
Databáze: Academic Search Ultimate